Clincosm LogoSign in Get a demo

t acute lymphoblastic leukemia

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

Recruiting
  • T Acute Lymphoblastic Leukemia
  • T Lymphoblastic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 11, 2023

T Acute Lymphoblastic Leukemia, Early T Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Italy (bone marrow

Recruiting
  • T Acute Lymphoblastic Leukemia
  • +3 more
  • bone marrow and/or peripheral blood samples withdrawal
  • Ancona, Italy
  • +9 more
Nov 24, 2022

B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Lymphoblastic Lymphoma Trial

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +5 more
  • Biospecimen Collection
  • +4 more
  • (no location specified)
Oct 28, 2022

Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide (procedure,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +21 more
  • Birmingham, Alabama
  • +219 more
Sep 15, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blasts 5 Percent or More of Bone Marrow Nucleated Cells,

Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +10 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 17, 2021

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax)

Recruiting
  • Acute Bilineal Leukemia
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2021

T Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Langfang (RD13-01 cell infusion)

Unknown status
  • T Acute Lymphoblastic Leukemia
  • T-lymphoblastic Lymphoma
  • RD13-01 cell infusion
  • Langfang, Hebei, China
    Hebei Yanda Ludaopei Hospital
Nov 3, 2020

B Acute Lymphoblastic Leukemia, Minimal Residual Disease, Recurrent Acute Lymphoblastic Leukemia Trial in Seattle (Laboratory

Terminated
Has Results
  • B Acute Lymphoblastic Leukemia
  • +3 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 11, 2020

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Recurrent Adult Acute Lymphoblastic Leukemia Trial in Seattle (drug,

Withdrawn
  • B Acute Lymphoblastic Leukemia
  • +8 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 9, 2018